Dextroamphetamine is a central nervous system stimulant that acts primarily by increasing dopamine and norepinephrine release and inhibiting their reuptake, which can potentially modulate pain perception and neurovascular mechanisms associated with cluster headaches. Its sympathomimetic properties may help constrict cerebral blood vessels and reduce neurogenic inflammation, potentially interrupting the pathophysiological cascade of cluster headache attacks.